2131 results about "Cysteine" patented technology

A pharmaceutical composition comprising a protein arginine methyltransferase 5 (PRMT5) inhibitor and a KRASG12C (Kirsten rat sarcoma viral oncogene homolog glycine-to-cysteine) inhibitor. The pharmaceutical composition can be used for treating various cancers, comprising solid tumors. The combined product can be used for treating any number of diseases associated with PRMT5 and / or KRASG12C.

The invention provides a method for preparing high-purity and fine-particle-size lithium sulfide based on carbon thermal reduction. The method comprises the following steps: weighing lithium sulfate monohydrate, an insoluble inorganic carbon source and cysteine in a set proportion to form a raw material mixture; mixing the raw material mixture with water according to a set solid-to-liquid ratio, performing ultrasonic dispersion to obtain homogeneous dispersion liquid, and enabling the dispersion liquid to pass through a nitrogen circulating spray dryer to obtain uniform and dry precursor powder; in a vacuum environment, carrying out segmented calcination to obtain a crude product lithium sulfide; and in a dry and anhydrous environment, washing the crude product lithium sulfide for multiple times by using absolute ethyl alcohol according to a set liquid-solid ratio to obtain an alcoholic solution containing lithium sulfide, and then obtaining lithium sulfide fine powder through a nitrogen circulating spray dryer. The invention solves the problems of side reaction, low purity, large product particles, uncontrollable particle size and the like of lithium sulfide prepared by a carbon thermal reduction method in the prior art.

The invention discloses a fatty acid modified coronavirus antigen and application thereof, and belongs to the field of biological medicine. The fatty acid modified coronavirus antigen contains fatty acid modified N-terminal cysteine (Cys) and a coronavirus antigen, and can contain a connecting structural domain; the coronavirus antigen is a coronavirus spike protein (S protein) receptor binding domain (RBD). The fatty acid modified coronavirus S protein RBD can be self-polymerized into nanoparticles, and compared with the RBD which is not subjected to fatty acid modification, the antigen can induce faster and higher humoral immunity through injection immunity, can induce mucosal immunity and humoral immunity through respiratory tract atomization immunity, and is a candidate mucosal vaccine with potential medical value.

The invention discloses a hydrophobic and oleophobic modified epoxy resin, which is prepared from the following components in parts by mass: 2 to 5 parts of thiolactone terminated fluorinated prepolymer, 15 to 16 parts of 4, 4 '-diaminodiphenylmethane, 0.13 to 0.14 part of base catalyst, 25 to 26.5 parts of epoxy resin and the balance of tetrahydrofuran solvent, wherein the thiolactone-terminated fluorinated prepolymer is prepared from thiolactone acrylamide, fluorinated acrylate and a photoinitiator in a mass ratio of (2-3): 1: (0.07-0.09) through a free radical polymerization copolymerization chemical reaction under the induction of ultraviolet light, and the thiolactone-terminated fluorinated prepolymer is obtained; wherein thiolactone acrylamide is prepared from DL-homocysteine thiolactone hydrochloride, a NaHCO3 solution and acryloyl chloride according to the mass ratio of 1: (1.3-1.5): (1.1-1.3), the oleophobic and hydrophobic modified epoxy resin provided by the invention effectively solves the problem that an epoxy resin coating in the prior art is poor in oleophobic performance and hydrophobic performance, and the oleophobic and hydrophobic modified epoxy resin has the advantages that the oleophobic and hydrophobic properties of the epoxy resin coating are improved; therefore, the oleophobic and hydrophobic properties of the epoxy resin coating are improved.

The invention belongs to the field of bioengineering, and particularly discloses a tryptophan synthetase mutant with improved enzymatic activity and application of the tryptophan synthetase mutant in production of L-cysteine. Compared with wild tryptophan synthetase from escherichia coli, the amino acid sequence of the tryptophan synthetase mutant has the advantages that a beta catalytic subunit has T69A, S143A, R219E and F280H site combined mutation. Researches show that the enzyme activity of the mutant is increased by 2.4 times compared with that of a wild type through enzyme activity determination and analysis of inducible expression and purification. The beneficial tryptophan synthetase mutant provided by the invention can efficiently biocatalyze L-serine and sodium hydrosulfide to synthesize L-cysteine, and has a better industrial application prospect.

The invention belongs to the field of biological medicine, and particularly relates to a respiratory syncytial virus F protein mutant and application thereof. The respiratory syncytial virus F protein mutant is characterized in that at least one pair of amino acid residues in an F1 subunit and / or an F2 subunit of F protein polypeptide are substituted by cysteine, and / or an F protein signal peptide part is substituted by a human immunoglobulin light chain signal peptide, and / or alanine A at the 107 site of a multi-base sequence is mutated into arginine R, lysine K at the 134 site is mutated into arginine R, and the amino acid residues in the F1 subunit and / or the F2 subunit of the F protein polypeptide are mutated into arginine. According to the invention, more neutralizing antibody epitopes can be exposed, the stable pre-fusion conformation is maintained, effective neutralizing antibody reaction and antibody binding reaction to the RSV subtypes A and B can be ensured, and the vaccine is suitable for various vaccine forms taking the RSV F protein as the antigen.

A method for visible light-mediated chemical modification of a polypeptide or protein based on cysteine includes the following steps: allowing a cysteine residue on a cysteine-containing oligopeptide, polypeptide, or protein to undergo a reaction with an activating reagent to generate a free radical precursor in situ; and subjecting the free radical precursor to desulfurization under photocatalytic condition, and allowing the generated free radical intermediate to undergo an addition reaction with an olefin or an alkyne, such that sulfhydryl removal and carbon-carbon bond construction are achieved to produce a chemical modification product of the polypeptide and protein. The method cleverly avoids the influence on the chiral center, and thus the chirality of the amino acid residue can be retained. The method is conducive to well avoiding the occurrence of side reactions, and thus the efficiency of the entire conversion is very high.

The invention relates to the technical field of microbial genetic engineering, in particular to a method for improving cordycepin synthesized by saccharomyces cerevisiae and saccharomyces cerevisiae engineering bacteria. According to the invention, codon-optimized 2 '-carbonyl-3'-deoxyadenosine reductase gene and 3 '-adenosine monophosphate phosphohydrolase gene from cordyceps militaris are expressed by using plasmids, and then the plasmids are transformed into host cells to obtain the saccharomyces cerevisiae engineering bacteria. And inoculating a seed solution obtained by seed culture of the activated saccharomyces cerevisiae engineering bacteria into a fermentation culture medium containing a metabolic effector, and carrying out fermentation culture to synthesize cordycepin. Metabolic effectors (Cu < 2 + >, Fe < 2 + >, Mg < 2 + >, Zn < 2 + >, citric acid, cysteine, aspartic acid, glycine, VB1 and tea polyphenol) are added into a fermentation culture medium strain, and the variety and concentration of the metabolic effectors are optimized, so that the yield and synthesis efficiency of cordycepin are remarkably improved. By using the combination of the strain obtained by the invention and the optimal effector, the yield of cordycepin in a fermentation tank reaches 2.9 g / L.

The invention relates to the field of polypeptide compositions, in particular to a polypeptide metal chelate and application thereof in the field of cosmetics, and the polypeptide metal chelate is formed by chelating a polypeptide compound and a metal ion compound. The structure of the polypeptide compound is [gamma-Glu] n-AA, n is greater than or equal to 1, and AA is selected from glycine, alanine, valine, leucine, isoleucine, methionine (methionine), proline, tryptophan, serine, tyrosine, cysteine, phenylalanine, asparagine, glutamine, threonine, asparaginic acid, glutamic acid, lysine, arginine or histidine; the polypeptide chelated zinc prepared by the invention has remarkable oil control and anti-inflammatory effects, and can be compounded with other raw materials to form cosmetics with oil control and acne removal effects.

Provided are a ligand-drug conjugate represented by general formula Pc-(L-D)n or a pharmaceutically acceptable salt thereof, and further provided is a linker for conjugation represented by formula (L). The linker can efficiently and highly selectively perform chemical conjugation with a thiol group on cysteine, and the antibody-drug conjugate formed has good stability.

The invention relates to the technical field of biology, in particular to a method for synthesizing S-sulfo-L-cysteine through multi-enzyme cascade catalysis. The invention provides a new route for biosynthesis of S-sulfo-L-cysteine, and a test result shows that serine, AMP, sodium hexametaphosphate and sodium thiosulfate are used as substrates, and the S-sulfo-L-cysteine is synthesized by a one-step method. A crude enzyme liquid which contains serine kinase, polyphosphoric acid-AMP phosphotransferase and phosphoserine dependent type S-sulfo-L-cysteine synthetase in which the background of tryptophanase and glutaredoxin cells is knocked out is used for synthesizing the S-sulfo-L-cysteine, the steps are simple, the product yield is high, the cost is low, and the method has a relatively strong industrial application prospect.

The invention discloses a 3 '-phosphoadenosine-5'-phosphoryl sulfate synthetase mutant and an application of the 3 '-phosphoadenosine-5'-phosphoryl sulfate synthetase mutant. Compared with a wild enzyme amino acid sequence as shown in SEQ ID NO.1, the amino acid sequence of the 3 '-adenosine-5'-phosphoryl sulfate synthetase mutant has one or two mutations in the 101 site, the 207 site and the 560 site; preferably, phenylalanine at the 101 site is mutated into tryptophan; cysteine at the 207th site is mutated into glycine; phenylalanine at the 560th site is mutated into tryptophan. The invention also provides a synthesis method and application of the 3 '-adenosine-5'-phosphoryl sulfuric acid. The APS intermediate product inhibition effect of hPAPSS1 is relieved through a point mutation technology, the substrate affinity of hPAPSS1 to ATP is improved, and a mutant enzyme with a high PAPS conversion rate is obtained; and the bifunctional enzyme hPAPSS1 is synthesized by heterologous expression of PAPS in escherichia coli, so that the acquisition of the enzyme is simplified, and the synthesis efficiency of PAPS is improved.

The invention belongs to the technical field of molecular marker assisted breeding, particularly relates to a molecular marker related to white spot resistance on a corn chromosome 4 and application, and particularly provides the molecular marker related to the corn white spot resistance, the gene of the molecular marker is a Zm00001eb168510 gene and / or a sequence as shown in SEQ ID NO: 1, the CDs sequence of the Zm00001eb168510 gene is as shown in SEQ ID NO: 2, and the CDs sequence of the Zm00001eb168510 gene is as shown in SEQ ID NO: 1. According to the invention, through many years of multi-site experiments, the white spot resistance QTL qMWS4-4 interval and the resistance SNP: 4-14146725 and the associated gene Zm00001eb168510 thereof are jointly localized on the corn chromosome 4, the SNP locus can be localized in different environments through QTL linkage analysis and GWAS association analysis, and 15.14% of phenotypic variation can be explained; the associated candidate functional gene mainly encodes cysteine protease superfamily protein, and a cysteine protease large family contains deubiquitination enzyme which plays an important role in plant development and stress response.

The present invention discloses a natural composite flavor enhancer and a preparation method thereof, comprising the following steps: using an ultramicro grinder to crush rice wine lees and wheat gluten powder to obtain ultramicro wheat gluten powder and ultramicro rice wine lees powder; taking the ultramicro wheat gluten powder, sterile water, and protease, mixing them evenly, carrying out enzymatic hydrolysis, inactivating the enzyme after the reaction ends, filtering, and taking the filtrate, namely the wheat gluten powder enzymatic hydrolysate, for standby; taking the wheat gluten powder enzymatic hydrolysate, ultramicro rice wine lees powder, and sterile water, mixing them evenly, carrying out enzymatic hydrolysis, inactivating the enzyme after the reaction ends, filtering, and taking the filtrate, namely the composite enzymatic hydrolysate, for standby; taking the composite enzymatic hydrolysate, cysteine, xylose, glucose, granulated sugar, and salt, mixing them and carrying out a thermal reaction to obtain a reaction solution; and preparing the natural flavor enhancer by spray drying. The present invention utilizes the natural enzyme system in rice wine lees to synergistically enzymatically hydrolyze wheat gluten powder to promote the release of umami amino acids, and further strengthens the umami by using thermal reaction technology.

The invention discloses a brassica rapa imago feed and a preparation method thereof, and belongs to the technical field of insect breeding. The Eye spot Brassica rapa adult feed comprises 11 to 15 parts of casein, 1 to 3 parts of Webster salt, 4 to 6 parts of cane sugar, 9 to 12 parts of cellulose powder, 0.2 to 0.4 part of L-cysteine, 0.2 to 0.3 part of choline chloride, 0.08 to 0.1 part of inositol, 0.325 to 0.4 part of composite vitamin, 2 to 3 parts of a nutritional ingredient ethanol solution, 12 to 14 parts of a nutritional ingredient aqueous solution, 1 to 2 parts of honey, 2 to 3 parts of agar powder, 0.03 to 0.04 part of cholesterol, 33 to 67 parts of apple jam, 0.3 to 4 parts of royal jelly and 80 to 120 parts of water. In addition, the invention also provides a preparation method of the feed for the Eye spot Brassica rapa imagoes. The feed for the Eye spot Brassica rapa adults can prolong the life of the adults and improve the egg laying amount at the same time.

The invention discloses a pharmaceutical composition for promoting angiogenesis and tissue regeneration and application thereof. The pharmaceutical composition of the present invention comprises an acidic secretory protein rich in cysteine, a disaccharide chain proteoglycan, and an XV-type collagen alpha1 chain. The biological material system loaded with the three types of proteins can promote angiogenesis, and can improve the tissue regeneration efficiency of bone, cartilage and skin defect areas.

The invention relates to the technical field of biology, and discloses a carbonyl reductase mutant and application thereof in enzymatic synthesis of chiral alcohol. The amino acid sequence as shown in SEQ ID NO.2 is subjected to mutation that 36th lysine is mutated into any one of aspartic acid, threonine and valine, or / and 125th histidine is mutated into any one of lysine, serine and leucine, or 170th histidine is mutated into any one of lysine, cysteine and leucine. The carbonyl reductase mutants, especially single-site mutants Mut-T75K, Mut-T75D and Mut-E216M and a combined mutant Mut-T75K-E216M, with activity improved to different extents compared with that of a wild type are obtained, have excellent relative enzyme activity, thermal stability and substrate tolerance, have relatively high activity and stability for various chiral alcohols, and can be used for preparing the carbonyl reductase mutants. The catalyst has the advantages of high catalytic activity, high thermal stability, strong substrate tolerance, easiness in fermentation and the like.

The invention belongs to the technical field of skin care product raw materials, and discloses an oligopeptide compound, a preparation method thereof, a beautifying composition and application. The oligopeptide compound has a structural formula of # imgabs0. The oligopeptide compound provided by the invention contains peptide fragments of antioxidant amino acids such as tyrosine (Tyr), beta-alanine (beta-Ala), cysteine (Cys) and proline (Pro), and the amino acids can directly participate in removal of free radicals or form a stable peptide structure to enhance the antioxidant effect; therefore, the oligopeptide compound with anti-oxidation and physiological repair effects is obtained. Meanwhile, a mild Fmoc route is adopted in the preparation method, the condensation reaction time of each step is short, the production period is greatly shortened, raw materials are convenient to obtain, the process is stable, the quality is controllable, the product yield and purity are high, and large-scale production can be achieved.

The invention discloses a preparation method and application of an antioxidant MXene-based flowing electrode material capable of realizing efficient capacitance defluorination, and belongs to the technical field of water treatment. The preparation method comprises the following steps: sequentially carrying out nitrogen doping and cysteine modification on MXene to obtain the antioxidant MXene-based flowing electrode material capable of realizing efficient capacitance defluorination. The MXene is prepared by a Lewis acid fused salt etching method. According to the method disclosed by the invention, the electrochemical performance of the MXene electrode is effectively improved, the conductivity of the MXene electrode is enhanced, the protection of terminal groups is realized through cysteine modification, and the oxidation resistance of the MXene electrode is improved. The anti-oxidation MXene-based flowing electrode material prepared by the invention has high specific surface area, large pore volume and multiple adsorption sites, and can realize specific efficient adsorption of fluorine ions through ion intercalation and special functional groups at end positions.

A boron carrying agent, a preparation method therefor, and a pharmaceutical formulation. The boron carrying agent contains compound 1, N-4-carboxyphenylboronic acid amide-threonine-phenylalanine-phenylalanine-tyrosine-glycine-glycine-serine-arginine-glycine-lysine-arginine-aspartic acid-aspartic acid-phenylalanine-lysine-threonine-glutamic acid-glutamic acid-tyrosine-cysteine, having a molecular formula of C114H158BN30O35S1 and a molecular weight of 2552.4, and further contains compound 2, N-4-carboxyphenylboronic acid amide-arginine-lysine-lysine-lysine-arginine-arginine-glutamine-arginine-arginine-arginine, and / or compound 3, N-4-carboxyphenylboronic acid amide-methionine-alanine-serine-methionine-threonine-glycine-glycine-glutamine-glutamine-methionine-glycine. Compounds 1-3 can serve as a targeted medicament for boron neutron capture therapy used for treating a cerebral glioma and a head and neck tumor.

The invention provides a method for arylation and cyclization of polypeptide, and the reaction process is as follows: the specific method comprises the following steps: under weakly acidic, neutral or weakly alkaline conditions, carrying out a chemical selective arylation reaction on linear polypeptide II containing two cysteine residues through a dichloro nitrogen-containing heteroaromatic ring reagent I, so as to construct a cyclized stable polypeptide III. The cyclized stable polypeptide III has improved stability and cell transmembrane properties under physiological conditions.

The invention provides an oxygen-carrying protein molecule and a preparation method and application thereof, and relates to the technical field of functional protein preparation, the oxygen-carrying protein molecule comprises at least one cysteine part and at least one histidine part, the cysteine part comprises acetyl or ethyl maleoyl, and the histidine part comprises histidine. The histidine moiety includes a benzimidazole derivative group. The benzimidazole derivative is adopted as an auxiliary molecule and participates in the modification process of the sulfydryl modified compound on the hemoglobin, the modification site selectivity is improved, the conformational change is reduced, and the modification degree is accurately controlled, so that the oxygen binding force P50 of the modified hemoglobin is effectively improved.

The invention relates to the technical field of pet feed additives, and discloses a feed additive capable of relieving animal hair falling and a preparation method of the feed additive capable of relieving animal hair falling. Comprising the following substances: 5 parts of an angelica sinensis extract, 10 parts of a cacumen biotae extract, 1.51 parts of vitamin B family, 0.1 part of vitamin H, 1 part of zinc, 0.1 part of selenium, 5 parts of methionine and 5 parts of cysteine. According to the feed additive capable of relieving animal hair falling, the hair quality can be improved, and hair falling can be reduced; the strength and the elasticity of hair are improved; healthy hair growth is promoted; the composition has the advantages that the health of the skin and hair follicles is enhanced, a better growth environment is provided for the hair, the healthy hair state of animals can be maintained, and the hair loss phenomenon caused by nutrition deficiency or environmental problems is reduced.

The invention belongs to the technical field of preparation of fluorescent powder, and particularly relates to double-shell narrow-band red-light fluorescent powder as well as a preparation method and application thereof. The narrow-band red-light fluorescent powder is Mn < 4 + >-doped potassium fluosilicate fluorescent powder, and the narrow-band red-light fluorescent powder is coated with a potassium fluosilicate inner shell layer and a cystine outer shell layer. The preparation method comprises the following steps: mixing a cysteine solution with the narrow-band red-light fluorescent powder, stirring, centrifuging, and drying the precipitate obtained by centrifuging to obtain the double-shell narrow-band red-light fluorescent powder. The surface of the prepared fluorescent powder is provided with the Mn < 4 + >-free potassium fluosilicate inner shell layer and the outer hydrophobic cystine layer, the surface of the core narrow-band red-light fluorescent powder is covered with the double-shell structure, the water resistance and the light-emitting characteristic of the narrow-band red-light fluorescent powder can be remarkably improved, and the wide application prospect is achieved.

The invention relates to a carbon dioxide electrocatalytic reduction catalyst, in particular to an L-cysteine modified nano-silver electrocatalyst and application thereof, and belongs to the technical field of carbon dioxide emission reduction and resource utilization and electrocatalytic material synthesis. A preparation method of the L-cysteine modified nano-silver electrocatalyst comprises the following steps: S1, dissolving silver nitrate in water to obtain a 0.05-100mM silver nitrate solution, adding the silver nitrate solution into ethylene glycol, and uniformly stirring; the volume ratio of the silver nitrate solution to the ethylene glycol is 1: (2-20); s2, L-cysteine is added into the mixed solution, microwave heating is performed after uniform stirring, obtained solids are centrifugally washed at least three times with ethyl alcohol and ultrapure water respectively, and the solids are dried in a vacuum drying box to obtain nano-silver particles; the molar ratio of the silver element to the L-cysteine is 1: (0.01-10). By improving the adsorption capacity of the electrocatalyst on active substances, high selectivity and high stability of the product CO in a CO2 in-situ conversion system are realized.

The invention provides a drug permeability clinical prediction model, a construction method thereof and a non-specific drug permeability evaluation method, and belongs to the technical field of biological medicine. The invention provides a construction method of a drug permeability clinical prediction model. According to the construction method, intestinal microorganism characteristics are introduced into model construction for the first time. The prediction performance of the constructed LGBM model containing the intestinal microorganism characteristics in the aspect of NAC permeability prediction is superior to that of other traditional business models. The invention also provides a serine-derived sphingolipid de novo synthesis pathway, which is different from the traditional sphingolipid de novo synthesis pathway, and is named as a cysteine sphingolipid metabolism pathway, NAC-derived cysteine may participate in the biosynthesis of microbial sphingolipid through covalent binding with palmitoyl-CoA, thereby damaging intestinal permeation of NAC.

The present invention is in the field of agricultural pathogen control. Methods and compositions are described for controlling plant diseases caused by pathogens, including fungi and oomycete phytopathogens. Chemicals were screened for activity as autophagy inhibitors. The screening method used a bioluminescence resonance energy transfer (BRET)-based high-throughput screening strategy to identify compounds that inhibit fungal ATG4 cysteine protease-mediated cleavage of ATG8 for autophagosome formation. Ebselen and ebselen analogs were identified as inhibitors of fungal pathogens ATG4-mediated ATG8 processing. Identified chemicals inhibit spore germination, hyphal development, and appressorium formation. The autophagy inhibitors significantly reduced the virulence of pathogens in their corresponding plant hosts. The invention also provides for compositions comprising the same, methods of making the same, and methods of controlling plant disease.

The invention relates to an indole hair dye based on air oxidation. The hair dye provided by the invention is characterized in that a chemical strong oxidant is not added, and oxygen in air can be catalyzed by using an air oxidation catalyst and a metal ion catalyst to naturally finish the oxidative polymerization process of indole substances (natural bionic melanin precursor substances). The used reducing agent is a combination of cysteine and a derivative thereof and sodium sulfite and a derivative thereof, the oxidative polymerization speed of indole substances can be controlled, and finally generated melanin macromolecules are embedded in hair cortex, so that white hair is obviously blackened. The natural oxidation process does not need hydrogen peroxide, destructive strong base or organic base, so that the use of harmful chemical reagents is reduced, the formula is simplified, the hair dyeing process is milder, potential hazards to hair and scalp are reduced, and the natural oxidation hair dye is safe, environmentally friendly and sustainable.

The present invention relates to: a temperature-sensitive hydrogel for cancer treatment; a photothermal composition comprising the hydrogel as an active ingredient; and a preparation method for the temperature-sensitive hydrogel for cancer treatment. The temperature-sensitive hydrogel of the present invention includes gold nanostars as active ingredients, and thus can generate heat by light irradiation, thereby exhibiting a photothermal therapy effect. In addition, the hydrogel temperature increases so that the release of nitric oxide (NO) from S-nitrosocysteine can be induced. In addition, the temperature-sensitive hydrogel of the present invention includes S-nitrosocysteine as an active ingredient so that, upon a temperature rise due to a photothermal reaction, the penetration of drugs into a tumor site can be improved by the release of NO, and at the same time, apoptosis of cancer cells can be directly caused; and includes an immunotherapy agent as an active ingredient so that tumor size can be effectively suppressed even with the passage of time. Therefore, as a material that enables complex treatment combined with photothermal therapy and immunotherapy, the temperature-sensitive hydrogel of the present invention having the aforementioned effect can be usefully utilized in the field of medicine for cancer treatment.

The invention belongs to the technical field of mRNA vaccines, and particularly relates to a self-replicating mRNA vaccine as well as a preparation method and application thereof. The self-replicating mRNA is transcribed from an alphavirus skeleton vector, the alphavirus skeleton vector comprises gene sequences of alphavirus non-structural proteins nsP2, nsP3 and nsP4 and mutated nsP1, and cysteine at the 492nd position of the mutated nsP1 is mutated into serine. The self-replicating mRNA provided by the invention has higher expression quantity and longer expression time for the target gene. The self-replicating mRNA is used for expressing IMP3 and can be prepared into a vaccine with good prevention and treatment effects on IMP3 positive tumors. Therefore, the invention has a good application prospect in the development of medicines and vaccines.